Contract for Clinical Validation Services in respect of the use of Mass Spectrometry for Covid-19 testing
Validation that mass spectrometry can act as a diagnostic screen for patient samples from NHS test centres (i.e. validating P1 to a clinical standard); and validation of workflow to certain specifications (i.e. turnaround time).
Buyer
Department of Health and Social Care (T&T)
Value
£75,787
Published
17 Mar 2021
Closes
5 Feb 2021
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Direct
Category
Services
Contract starts
5 Feb 2021
Contract ends
26 Mar 2021
CPV classifications
73111000
Research laboratory services
Lots
Lot default Contract for Clinical Validation Services in respect of the use of Mass Spectrometry for Covid-19 testing
£75,787
Validation that mass spectrometry can act as a diagnostic screen for patient samples from NHS test centres (i.e. validating P1 to a clinical standard); and validation of workflow to certain specifications (i.e. turnaround time).
Delivery: United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
17 Mar 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
P2_Contract_Variation_Letter__MFT_Redacted
Not provided
P2_Contract_Variation_Letter__MFT_Redacted
Link
Specification_and_Tender_Response_Document__MFT_version_Redacted
Not provided
Specification_and_Tender_Response_Document__MFT_version_Redacted
Link
P2_Lab__Services_Contract__MFT_Redacted
Not provided
P2_Lab__Services_Contract__MFT_Redacted
Link
Contains public sector information licensed under the Open Government Licence v3.0.